Nymox Pharmaceutical Corp (NYMXF)

Currency in USD
0.0200
0.0000(0.00%)
Closed·
NYMXF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.02000.0200
52 wk Range
0.00020.1999
Key Statistics
Prev. Close
0.02
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.0002-0.1999
Volume
600
Average Volume (3m)
19.36K
1-Year Change
-68.3244%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NYMXF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Nymox Pharmaceutical Corp News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Earnings

Latest Release
Jun 03, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NYMXF Income Statement

Compare NYMXF to Peers and Sector

Metrics to compare
NYMXF
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.6x−0.4x
PEG Ratio
0.12−0.060.00
Price/Book
-1.6x2.6x
Price / LTM Sales
-0.9x3.0x
Upside (Analyst Target)
-147.9%54.5%
Fair Value Upside
Unlock11.1%7.0%Unlock

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a simple, cost-effective test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer’s disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.69K0.01%113.70
Other Institutional Investors
29.42K0.03%588.30
Public Companies & Retail Investors
104.99M99.97%2.10M
Total
105.03M100.00%2.1M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
First Citizens Financial Corp.0.03%35,1001
Master Investment Portfolio - Active Stock Master Portfolio0.01%5,6850

FAQ

What Is the Nymox Pharmaceutical (NYMXF) Stock Price Today?

The Nymox Pharmaceutical stock price today is 0.0200 USD.

What Stock Exchange Does Nymox Pharmaceutical Trade On?

Nymox Pharmaceutical is listed and trades on the OTC Markets.

What Is the Stock Symbol for Nymox Pharmaceutical?

The stock symbol for Nymox Pharmaceutical is "NYMXF."

What Is the Nymox Pharmaceutical Market Cap?

As of today, Nymox Pharmaceutical market cap is 2.1000M USD.

What Is Nymox Pharmaceutical's Earnings Per Share (TTM)?

The Nymox Pharmaceutical EPS (TTM) is -0.0500.

From a Technical Analysis Perspective, Is NYMXF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Nymox Pharmaceutical Stock Split?

Nymox Pharmaceutical has split 0 times.

How Many Employees Does Nymox Pharmaceutical Have?

Nymox Pharmaceutical has 16 employees.

What is the current trading status of Nymox Pharmaceutical (NYMXF)?

As of Sep 19, 2026, Nymox Pharmaceutical (NYMXF) is trading at a price of 0.0200 USD, with a previous close of 0.0200 USD. The stock has fluctuated within a day range of 0.0200 USD to 0.0200 USD, while its 52-week range spans from 0.0002 USD to 0.1999 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.